David S. Perlin

24.8k total citations · 6 hit papers
301 papers, 18.8k citations indexed

About

David S. Perlin is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, David S. Perlin has authored 301 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Infectious Diseases, 159 papers in Epidemiology and 81 papers in Molecular Biology. Recurrent topics in David S. Perlin's work include Antifungal resistance and susceptibility (191 papers), Fungal Infections and Studies (131 papers) and ATP Synthase and ATPases Research (38 papers). David S. Perlin is often cited by papers focused on Antifungal resistance and susceptibility (191 papers), Fungal Infections and Studies (131 papers) and ATP Synthase and ATPases Research (38 papers). David S. Perlin collaborates with scholars based in United States, United Kingdom and Denmark. David S. Perlin's co-authors include Steven Park, Guillermo García‐Effrón, Maiken Cavling Arendrup, Ana Alastruey‐Izquierdo, Yanan Zhao, Riina Rautemaa‐Richardson, Susan J. Howard, Cristina Jiménez‐Ortigosa, James E. Haber and Milena Kordalewska and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

David S. Perlin

296 papers receiving 18.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The global problem of antifungal resistance: prevalence, mechanisms, and management

2017 757 citations David S. Perlin et al. profile →
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

2013 620 citations Cristina Jiménez‐Ortigosa, David S. Perlin et al. Clinical Infectious Diseases profile →
Frequency and Evolution of Azole Resistance inAspergillus fumigatusAssociated with Treatment Failure1

2009 616 citations David S. Perlin, David W. Denning et al. profile →
Mechanisms of Antifungal Drug Resistance

2014 448 citations David S. Perlin et al. profile →
A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

2017 421 citations Milena Kordalewska, David S. Perlin et al. profile →
A naturally inspired antibiotic to target multidrug-resistant pathogens

2022 158 citations Steven Park, David S. Perlin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David S. Perlin	13.3k	10.5k	4.1k	2.7k	2.2k	301	18.8k
Frank C. Odds	15.5k 1.2×	11.0k 1.0×	5.4k 1.3×	2.7k 1.0×	1.4k 0.7×	265	21.3k
Dominique Sanglard	12.6k 0.9×	9.2k 0.9×	5.0k 1.2×	3.0k 1.1×	1.9k 0.9×	227	18.5k
Cornelia Lass‐Flörl	14.1k 1.1×	11.0k 1.0×	1.9k 0.5×	1.8k 0.7×	1.6k 0.7×	466	18.8k
Scott G. Filler	13.6k 1.0×	9.6k 0.9×	4.1k 1.0×	1.5k 0.6×	1.3k 0.6×	229	18.1k
Theodore C. White	7.6k 0.6×	6.4k 0.6×	3.7k 0.9×	3.1k 1.1×	1.4k 0.7×	115	13.8k
S. A. Messer	15.2k 1.1×	12.0k 1.1×	1.5k 0.4×	1.3k 0.5×	1.4k 0.6×	201	17.2k
Maiken Cavling Arendrup	11.1k 0.8×	9.0k 0.9×	1.5k 0.4×	1.5k 0.6×	1.1k 0.5×	245	14.8k
Arnaldo Lopes Colombo	12.1k 0.9×	10.0k 1.0×	1.7k 0.4×	1.3k 0.5×	960 0.4×	290	15.1k
John R. Perfect	24.1k 1.8×	24.1k 2.3×	5.7k 1.4×	5.3k 2.0×	2.2k 1.0×	439	34.1k
Russell E. Lewis	11.1k 0.8×	9.5k 0.9×	1.5k 0.4×	1.1k 0.4×	2.2k 1.0×	289	15.7k

Countries citing papers authored by David S. Perlin

Since Specialization

Citations

This map shows the geographic impact of David S. Perlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Perlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Perlin more than expected).

Fields of papers citing papers by David S. Perlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Perlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Perlin. The network helps show where David S. Perlin may publish in the future.

Co-authorship network of co-authors of David S. Perlin

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Perlin. A scholar is included among the top collaborators of David S. Perlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Perlin. David S. Perlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kordalewska, Milena, et al.. (2023). Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance. Antimicrobial Agents and Chemotherapy. 67(6). e0042323–e0042323. 19 indexed citations

Daneshnia, Farnaz, João Nóbrega de Almeida, Amir Arastehfar, et al.. (2022). Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU. Emerging Microbes & Infections. 11(1). 2264–2274. 33 indexed citations

Almeida, João Nóbrega de, Cristina Jiménez‐Ortigosa, Elaine Cristina Francisco, Arnaldo Lopes Colombo, & David S. Perlin. (2022). ERG11 Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles. Antimicrobial Agents and Chemotherapy. 66(12). e0110122–e0110122. 2 indexed citations

Garcia‐Rubio, Rocio, et al.. (2021). Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells. mBio. 12(4). e0195921–e0195921. 20 indexed citations

Arastehfar, Amir, João Nóbrega de Almeida, David S. Perlin, et al.. (2021). Multidrug-resistantTrichosporonspecies: underestimated fungal pathogens posing imminent threats in clinical settings. Critical Reviews in Microbiology. 47(6). 679–698. 17 indexed citations

Tóth, Zoltán, David S. Perlin, Rudolf Gesztelyi, et al.. (2019). Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis. Infection and Drug Resistance. Volume 12. 1805–1814. 5 indexed citations

Sarkar, Biplab, Zain Siddiqui, Peter K. Nguyen, et al.. (2019). Membrane-Disrupting Nanofibrous Peptide Hydrogels. ACS Biomaterials Science & Engineering. 5(9). 4657–4670. 36 indexed citations

Vinnard, Christopher, et al.. (2019). Adipose Tissue Regulates Pulmonary Pathology during TB Infection. mBio. 10(2). 29 indexed citations

Hou, Xin, Kelley R. Healey, Erika Shor, et al.. (2019). Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata. Emerging Microbes & Infections. 8(1). 1619–1625. 40 indexed citations

10.

Vickers, Clare, Ajanta Chakraborty, Natalia Kurepina, et al.. (2018). Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo. Journal of Medicinal Chemistry. 61(18). 8337–8352. 39 indexed citations

11.

Healey, Kelley R. & David S. Perlin. (2018). Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata. Journal of Fungi. 4(3). 105–105. 115 indexed citations

12.

Ishimaru, Toshiyuki, et al.. (2013). Molecular characterization of AfuFleA, an l-fucose-specific lectin from Aspergillus fumigatus. Journal of Infection and Chemotherapy. 19(6). 1021–1028. 19 indexed citations

13.

Endimiani, Andrea, Kristine M. Hujer, Andrea M. Hujer, et al.. (2011). Are We Ready for Novel Detection Methods to Treat Respiratory Pathogens in Hospital-Acquired Pneumonia?. Clinical Infectious Diseases. 52(suppl_4). S373–S383. 57 indexed citations

14.

Zhao, Yanan, Steven Park, Barry N. Kreiswirth, et al.. (2009). Rapid Real-Time Nucleic Acid Sequence-Based Amplification-Molecular Beacon Platform To Detect Fungal and Bacterial Bloodstream Infections. Journal of Clinical Microbiology. 47(7). 2067–2078. 65 indexed citations

15.

García‐Effrón, Guillermo, Säntosh K. Katiyar, Steven Park, Thomas D. Edlind, & David S. Perlin. (2008). A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis , Candida orthopsilosis , and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility. Antimicrobial Agents and Chemotherapy. 52(7). 2305–2312. 255 indexed citations

16.

Hauser, Philippe M., Katrien Lagrou, Cornelia Lass‐Flörl, et al.. (2008). Clinical performance of FXG: RESP (Asp+) assay for Pneumocystis jirovecii on respiratory specimens. Lirias (KU Leuven). 1 indexed citations

17.

Lass‐Flörl, Cornelia, Jacques Billé, David S. Perlin, et al.. (2008). Clinical performance of FXG(tm): RESP (Asp+) assay for aspergillus on respiratory specimens. Clinical Microbiology and Infection. 14. 1 indexed citations

18.

Park, Steven & David S. Perlin. (2005). Establishing Surrogate Markers for FluconazoleResistance in Candida albicans. Microbial Drug Resistance. 11(3). 232–238. 45 indexed citations

19.

Park, Steven, et al.. (2000). Cross-Resistance of Clinical Isolates of Candida albicans and Candida glabrata to Over-the-Counter Azoles Used in the Treatment of Vaginitis. Microbial Drug Resistance. 6(2). 155–161. 47 indexed citations

20.

Perlin, David S.. (1998). Ion pumps as targets for therapeutic intervention: Old and new paradigms. Electronic Journal of Biotechnology. 1(2). 21–22. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact